Image de couverture de This is Going to Hurt: Secret Diaries of a Junior Doctor

This is Going to Hurt: Secret Diaries of a Junior Doctor

Écouter un extrait
La meilleure offre de la saison

0,99 €/mois pendant 3 mois + 15 € de crédit Audible

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible.
Profiter de l’offre
L'offre prend fin le 28 décembre 2026.
Plus d'offres

This is Going to Hurt: Secret Diaries of a Junior Doctor

De : Adam Kay
Lu par : Adam Kay
Profiter de l’offre

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible. L'offre se termine le 28 décembre 2026.

Acheter pour 16,78 €

Acheter pour 16,78 €

La meilleure offre de la saison | 0,99 €/mois pendant les 3 premiers mois + 15 € de crédit Audible

6,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce titre

Read by the author, Adam Kay.

The multi-million copy bestseller

Book of the Year at The National Book Awards

‘Painfully funny. The pain and the funniness somehow add up to something entirely good, entirely noble and entirely loveable.' - Stephen Fry

Welcome to the life of a junior doctor: 97-hour weeks, life and death decisions, a constant tsunami of bodily fluids, and the hospital parking meter earns more than you.

Scribbled in secret after endless days, sleepless nights and missed weekends, Adam Kay's This is Going to Hurt provides a no-holds-barred account of his time on the NHS front line. Hilarious, horrifying and heartbreaking, this diary is everything you wanted to know – and more than a few things you didn't – about life on and off the hospital ward.

Sunday Times Number One Bestseller for over eight months and winner of a record FOUR National Book Awards: Book of the Year, Non-Fiction Book of the Year, New Writer of the Year and Zoe Ball Book Club Book of the Year.

This edition includes extra diary entries and a new afterword by the author.

Akademiker & Spezialisten Medizin
adbl_web_anon_alc_button_suppression_t1
Aucune critique pour le moment